Recent Articles
-
August 18, 2016 Review ArticleAbstract Background/Aims: Decreased trough levels of IFX (TLI) and antibodies to infliximab(ATI) are associated with loss of response (LOR) in Crohn’s disease. Two prospective studies were conducted to determine whether TLI or ATI correlates better with LOR.....